Molecular Diagnostics for Everyone
The World’s First Low‑Cost, High‑Throughput,
Near-Patient Molecular Diagnostic Test System
The World’s first Low-Cost, High‑Throughput,
Near-Patient Molecular Diagnostic Test System
Fast MDx is a Social Enterprise which provides molecular diagnostic testing
that will benefit society and have less impact on the environment
We align with the UK’s National Health Service commitment to delivering a Net Zero NHS by 2040
And with almost half of the World’s population having little or no access to diagnostics,
our goal is to provide affordable molecular diagnostics in more countries and in more settings
Low Cost Testing...
No CapEx as the Fast MDx platform is lent as part of the low cost test contract
No packaging cost
No transportation costs
No Biosecure lab overheads
Single technician operation
Ultra-Fast Fully Automated Results...
Faster Results
Earlier treatment
Better outcomes
Reduced spread of infectious disease
Near-Patient High- Throughput Testing...
1000+ Patient
test results per 8 hour shift
5 times more efficent than manual test processing
Lowest Carbon Footprint...
Near-Patient
eliminates transportation
and packaging
The NGx2
Ultra-Fast qPCR
thermal cycle minimizes
electrical use
Fully automated
optimized sample processing reduces
handling errors and the need to retest
Low Cost Testing
Ultra-Fast Fully Automated Results
No CapEx as the Fast MDx platform is lent as part of the low cost test contract
No packaging cost
No transportation costs
No Biosecure lab overheads
Single technician operation
Faster Results
Earlier treatment
Better outcomes
Reduced spread of infectious disease
Lowest Carbon Footprint
Near-Patient High- Throughput Testing
1000+ Patient
test results per 8 hour shift
5 times more efficient than manual test processing
Near-Patient
eliminates transportation
and packaging
The NGx2
Ultra-Fast qPCR
thermal cycle minimizes
electrical use
Fully automated
optimized sample processing reduces
handling errors and the need to retest
PRECISION
TESTING
HIGH-
THROUGHPUT
LOW COST
GREENER
TESTING
ULTRA-FAST
RESULTS
Fast MDx receives ISO 13485:2016 certification, setting out the requirements for quality management systems for diagnostics and medical devices.
A review funded by the Bill and Melinda Gates Foundation perfectly explains the greater need for high-throughput Point-of-Care preparedness that only the Fast MDx platform offers.
In a study reported in Nature on 25 September 2023 an immune system biomarker combinations was identified that distinguish Long COVID (LC) cases from those with no persisting symptoms.
COVID-19 metrics have been on the rise in the U.S. for about a month now, indicating that they’re experiencing a summer surge.
